Application value of multimodal ultrasound in diagnosis and guided biopsy of cervical lymph nodes

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300075077

Enrollment

Unknown

Registered

2023-08-24

Start date

2023-08-25

Completion date

Unknown

Last updated

2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical lymph nodes

Interventions

Gold Standard:pathological diagnosis

Index test:Conventional ultrasound, contrast-enhanced ultrasound, elastic ultrasound, needle biopsy

Eligibility

Sex/Gender

All

Age

5 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Routine ultrasound examination suspicious abnormal cervical lymph nodes; ?Preoperative multimodal ultrasonography and lymph node puncture biopsy were accepted; ? It was resected by puncture biopsy or surgery the pathological results were obtained.

Exclusion criteria

Exclusion criteria: ? Hypersensitivity to ultrasound contrast agent; ? Have received cervical radiation or chemotherapy; ? Had undergone neck-related surgery before ultrasound examination; ? No or unclear pathological results; ? unable to cooperate; ? serious heart, lung, liver, kidney dysfunction, malignant tumors or blood diseases; ? Severe coagulation dysfunction.

Design outcomes

Primary

Measure	Time frame
Contrast-enhanced ultrasound related parameters;Elastic ultrasound related parameters;Efficacy of needle biopsy;Predictors of malignant lymph nodes;Accuracy ;Sensitivity ;Specificity ;	—

Secondary

Measure	Time frame
Related parameters of conventional ultrasound;	—

Countries

China

Contacts

Public ContactXiaolian Li

The Longyan First Affiliated Hospital of Fujian Medical University

309047178@qq.com+86 152 0607 9011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026